CD154: the atherosclerotic risk factor in rheumatoid arthritis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD154: the atherosclerotic risk factor in rheumatoid arthritis?

Published:2013-02 Issue:1 Volume:15 Page:
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Hassan Ghada S,Yacoub Daniel,Alaaeddine Nada,Nadiri Amal,Merhi Yahye,Mourad Walid

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/ar4153.pdf

Reference67 articles.

1. Peters AL, Stunz LL, Bishop GA: CD40 and autoimmunity: the dark side of a great activator. Semin Immunol. 2009, 21: 293-300. 10.1016/j.smim.2009.05.012.

2. Schonbeck U, Libby P: CD40 signaling and plaque instability. Circ Res. 2001, 89: 1092-1103. 10.1161/hh2401.101272.

3. Van Doornum S, McColl G, Wicks IP: Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis. Arthritis Rheum. 2002, 46: 862-873. 10.1002/art.10089.

4. Montecucco F, Mach F: Atherosclerosis is an inflammatory disease. Semin Immunopathol. 2009, 31: 1-3. 10.1007/s00281-009-0146-7.

5. Cavagna L, Boffini N, Cagnotto G, Inverardi F, Grosso V, Caporali R: Atherosclerosis and rheumatoid arthritis: more than a simple association. Mediators Inflamm. 2012, 2012: 147354-

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ectodomain Shedding by ADAM17 Increases the Release of Soluble CD40 from Human Endothelial Cells under Pro-Inflammatory Conditions;Cells;2023-07-25

2. An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases;International Journal of Pharmaceutics;2021-11

3. CD154 inhibits death of T cells via a Cis interaction with the α5β1 integrin;PLOS ONE;2020-08-03

4. Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis;Scientific Reports;2018-02-01

5. Oleanolic acid protects against pathogenesis of atherosclerosis, possibly via FXR-mediated angiotensin (Ang)-(1–7) upregulation;Biomedicine & Pharmacotherapy;2018-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3